ILMN: Illumina, Inc.

Stock

About

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Year Founded
1998
Employees
10,590
Sector
Health Care
HQ Location
San Diego, CA

Current Value

$133.99

1 Year Return

$38.78
40.73%

Key Details

Market Cap

$21.41B

P/E Ratio

-13.5

1Y Stock Return

44.38%

1Y Revenue Growth

-1.68%

Dividend Yield

0.00%

Price to Book

10.0

Strategies that include
ILMN

Medium risk

$2,200

Tech 100

growth
balanced
growth income

This index is closely related to the Nasdaq-100 Index, comprising major tech and growth-oriented companies. It aims to capture the tech sector's long-term growth prospects through exposure to the innovative and leading tech companies listed on the Nasdaq exchange.

Top Sector

Information Technology

Top Holdings

Return

+20.62%

Expense Ratio

0.00%

Holdings

101

Medium risk

$5,200

Growth Stocks

growth
balanced
growth income

Growth Stocks focuses on companies with strong growth prospects, often found in sectors driving innovation and technological advancement. This ETF invests in companies demonstrating robust revenue and earnings growth, including technology giants, healthcare innovators, and consumer discretionary leaders.

Top Sector

Information Technology

Top Holdings

Return

+18.77%

Expense Ratio

0.00%

Holdings

180

Medium risk

$3,600

USA Mid-Cap Companies

growth
balanced
growth income

Targeting mid-sized U.S. companies, striking a balance between growth potential and stability. Investing in sectors like industrials, technology, consumer goods, and healthcare, it offers exposure to companies with established market positions and growth opportunities.

Top Sector

Industrials

Top Holdings

Return

+11.46%

Expense Ratio

0.00%

Holdings

310

Medium risk

$13,000

Health Care Sector

growth
balanced
growth income

This Strategy focuses on healthcare companies, including pharmaceuticals, biotechnology, healthcare providers, and medical equipment firms. Offering exposure to a sector driven by demographic trends and ongoing medical advancements, it's a strategic choice for investors considering healthcare's long-term growth potential.

Top Sector

Health Care

Top Holdings

Return

+8.40%

Expense Ratio

0.00%

Holdings

331

High risk

$1,000

ARK Innovation ETF

speculation
maximum growth

The ARKK fund was designed to seek long term capital from companies globally involved with, or that benefit from, disruptive innovation.

Top Sector

Financials

Top Holdings

Return

+4.55%

Expense Ratio

0.00%

Holdings

31

Medium risk

$33,000

US 1000

growth
balanced
growth income

This strategy tracks a market-cap-weighted index of the 1000-largest US companies. It offers broad exposure to the US equity market, encompassing a diverse range of sectors and industries. By investing in this fund, you gain access to the performance of large and well-established companies within the US economy.

Top Sector

Information Technology

Top Holdings

Return

+15.03%

Expense Ratio

0.00%

Holdings

995

Medium risk

$5,000

US Mid Cap

growth
balanced
growth income

This strategy tracks a market-cap-weighted index of mid-cap US companies. This strategy offers targeted exposure to the growth potential of mid-sized businesses within the US market. With a diversified portfolio of holdings, it provides investors with a comprehensive approach to capturing the mid-cap segment's performance.

Top Sector

Industrials

Top Holdings

Return

+11.00%

Expense Ratio

0.00%

Holdings

400

Create your own
strategy with

ILMN
Three dimensional double logo

Stock's related to
ILMN

Correlated Stocks

NameCorrelationMarket CapReturn % (1 Year)Div Yield %
RVTY55.14%$13.38B+23.61%0.26%
TRMB51.14%$17.01B+61.09%0.00%
BXP48.97%$12.56B+48.12%4.92%
BIO47.57%$8.98B+4.73%0.00%
HHH47.37%$3.98B+14.89%0.00%
PPBI46.96%$2.67B+20.00%4.75%
VCYT46.92%$3.03B+55.48%0.00%
ADPT46.91%$661.15M+6.16%0.00%
VBTX46.87%$1.58B+53.68%2.75%
MG46.76%$12.29B-21.35%4.47%
A46.34%$36.11B+1.43%0.75%
HOMB45.87%$6.11B+41.20%2.45%
TMO45.74%$194.74B+5.54%0.30%
OZK45.69%$5.44B+17.21%3.30%
ASB45.55%$3.95B+48.10%3.36%
HWC45.46%$4.92B+42.32%2.46%
KEY45.35%$18.83B+58.20%4.30%
TRMK45.29%$2.32B+69.09%2.44%
LC45.08%$1.69B+175.00%0.00%
PACB45.05%$471.05M-79.23%0.00%

Uncorrelated Stocks

NameCorrelationMarket CapReturn % (1 Year)Div Yield %
PBT-0.02%$606.38M-27.11%5.87%
DLNG0.04%$161.93M+73.23%0.00%
UTI-0.05%$1.07B+73.54%0.00%
GOGL0.06%$2.39B+35.11%8.40%
LLY-0.07%$692.74B+23.14%0.71%
DELL-0.12%$99.00B+84.60%1.24%
SNCR-0.15%$97.34M+78.17%0.00%
RNR-0.15%$13.74B+23.09%0.58%
CANG0.21%$253.50M+212.50%0.00%
FLXS0.22%$301.86M+215.00%1.02%
ATGE0.24%$3.29B+55.26%0.00%
CHD0.26%$27.18B+19.50%1.03%
LPTH0.29%$62.27M+33.05%0.00%
AIZ-0.32%$11.24B+33.00%1.31%
EG0.39%$15.92B-8.98%2.02%
OHI0.42%$10.84B+26.02%6.71%
SBLK0.44%$2.38B+2.30%10.64%
RGA-0.44%$14.97B+41.90%1.52%
WRB0.45%$22.94B+29.98%0.69%
NHTC0.60%$61.83M+0.19%14.81%

Inversely Correlated Stocks

NameCorrelationMarket CapReturn % (1 Year)Div Yield %
MCK-17.59%$78.15B+35.51%0.42%
PULM-15.69%$19.83M+202.98%0.00%
ABEO-10.91%$256.04M+41.25%0.00%
ACGL-10.25%$36.00B+16.84%0.00%
PGR-9.36%$149.10B+57.29%0.45%
CBOE-9.16%$21.46B+15.84%1.11%
TCTM-7.33%$8.10M-42.99%0.00%
HUSA-6.60%$16.69M-11.56%0.00%
OXBR-6.45%$19.05M+178.18%0.00%
TGS-5.73%$1.97B+116.04%0.00%
LPLA-5.45%$23.55B+38.13%0.38%
MNOV-5.24%$93.19M+2.15%0.00%
NEUE-4.11%$40.93M-34.13%0.00%
VZIO-3.80%$2.29B+67.76%0.00%
BTCT-3.57%$42.61M+353.33%0.00%
AJG-3.52%$64.17B+17.51%0.80%
SYPR-3.50%$32.23M-26.32%0.00%
WHLM-2.89%$17.64M-29.34%0.00%
PRPO-2.78%$9.10M-13.65%0.00%
TEO-2.60%$1.69B+87.97%0.00%

ETF's related to
ILMN

News

Yahoo

Agreement will expand worldwide access and better position Myriad’s GIS as a potential companion diagnostic across multiple potential tumor typesSALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced updates to its agreement with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies. Myriad’s gold-standard Genomic Instability Score (GIS) to determine Homologous Re

Yahoo

Kennedy would oversee the National Institutes of Health as head of the Department of Health and Human Services.

SeekingAlpha

Illumina, Inc. (NASDAQ:ILMN) Wolfe Research 2024 Healthcare Conference Call November 20, 2024 9:20 AM ETCompany ParticipantsAnkur Dhingra - Chief Financial...

Yahoo

Illumina plans for the global rollout of TruSight Oncology 500 v2, a new version of its NGS cancer assay, by mid-2025.

Yahoo

Illumina's new TSO 500 v2 assay aims to enable CGP of tumors, bolstering its TruSight Oncology portfolio.

Yahoo

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will release TruSight™ Oncology 500 v2 (TSO 500 v2), a new version of its flagship cancer research assay to enable comprehensive genomic profiling (CGP). The assay is currently under development, with global release planned for mid-2025. Detailed plans for the product will be shared November 21 in a spotlight presentation at the annual meeting of the Association of Molecular Pat

Disclaimer

Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.

Design your own stock index

© Double Finance, 2024

Double is a registered investment adviser with the US Securities and Exchange Commission (SEC). While such registration does not imply a certain level of skill, it does require us to follow federal regulations that protect you, the investor. By law, we must provide investment advice that is in the best interest of our client. Please refer to Double's Form CRS for important additional information.

The publicly available portions of the Platform (i.e., the sections of the Platform that are available to individuals who are not party to a Client Agreement - including double.finance) are provided for educational purposes only and are not intended to provide legal, tax, or financial planning advice. To the extent that any of the content published on publicly available portions of the Platform may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Nothing on the publicly available portions of the Platform should be construed as a solicitation or offer, or recommendation, to buy or sell any security. All charts, figures, and graphs on the publicly available websites are for illustrative purposes only. Before investing, you should consider whether any investment, investment strategy, security, other asset, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. You are also encouraged to consult your legal, tax, or investment professional regarding your specific situation. Registration does not imply a certain level of skill or training.

Investing involves risk. The value of your investment will fluctuate, and you may gain or lose money.

The contents of the Platform may contain forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates, and projections about the financial industry, the economy, or Global Predictions itself. Forward-looking statements are not guarantees of the underlying expected actions or future performance and future results may differ significantly from those anticipated by the forward-looking statements. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statements.

¹ Data as of July 2024.

² Availability of tax loss harvesting depends on portfolio diversity.

³ As of November 8, 2024. The optional Cash Sweep program takes the cash sitting in your brokerage account and moves it to an FDIC-insured interest-earning deposit account. The current yield is 1.0%, rates subject to change at any time. The cash sweep program is made available in coordination with Apex Clearing Corporation. Please read the Important Disclosures for more information.

⁴ This analysis calculator tool is for illustrative purposes only and is not financial advice. We do not guarantee the accuracy of the results or their relevance to your particular circumstances. This calculator uses hypothetical historical data and does not take into account the effect of taxes on a taxable account. Hypothetical historical data is no guarantee of future performance and this calculator is not intended to predict actual performance. The input of different time periods, amounts, and fees will vary calculator results. Average ETF fee is based on the AUM weighted average of US ETFs as of September 2024, see more information. Note that you can purchase ETFs through Double, which may incur additional fees.

Full pricing details along with an FAQ can be found here

Data displayed in charts and graphics above are for illustrative purposes only and do not reflect actual investment results and are not a guarantee of future results.

By using double.finance, you accept our and . Double is only available to US residents.

See Double Finance Form ADV Part IIA for additional information. Double does not guarantee that the results of its advice, recommendations, or the objectives of its direct index or cash management strategies will be achieved. We make no assurance that the investment process will consistently lead to successful investing. Before you invest, you should carefully review and consider your investment objectives as well as the risks, charges, and expenses of the underlying securities. There is at least a $1,000 account minimum required to participate in Double's strategies, although some strategies may have higher minimums.

Double does not provide tax, or legal advice. Double's website, brokerage, and advisory services are not intended for persons of any jurisdiction where Double is not authorized to do business. Tax savings will vary from client to client due to many factors including market conditions, tax characteristics of securities, client-imposed investment restrictions, client tax rate or status, and changes in tax regulations.